US Edition
8 Articles
8 Articles
McDonald’s shares slump as weight-loss drugs spur rare sell rating
(Bloomberg) — McDonald’s Corp. shares slumped on Tuesday after Redburn Atlantic slapped the burger chain with its sole sell rating, saying shifting consumer patterns due to weight-loss drugs and inflation are cause for concern.
The behaviour of the U.S. consumer questions and analysts worry about the trajectory of the results. McDonald's action costs it.
The US and China resume their talks in London to avoid an escalation in their tariff war. Delegations focus on reaffirming key agreements for the export of technological goods, while Wall Street analysts anticipate a possible rebound in the S&P 500. On the other hand, McDonald’s actions fall this Tuesday after an unusual Redburn Atlantic “sale” rating. The firm cited the impact of weight loss drugs and inflation as major concerns for the burger …
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
To view factuality data please Upgrade to Premium
